Indication
Patient Preference
2 clinical trials
6 products
Product
AzacitidineProduct
Oral decitabine/cedazuridineClinical trial
A Phase 3b, Randomized, Open-Label, Double Crossover Study Comparing Treatment Preference Between Oral Decitabine/Cedazuridine and Azacitidine in Adult Patients With IPSS R Intermediate Myelodysplastic Syndrome, Low Blast Acute Myeloid Leukemia, IPSS Intermediate-2 or High Risk Myelodysplastic Syndrome or Chronic Myelomonocytic LeukemiaStatus: Recruiting, Estimated PCD: 2025-04-01
Product
Oral decitabine/CedazuridineProduct
DaratumumabClinical trial
Prospective, Multicenter, Non-interventional Study to Evaluate Patient and Healthcare Provider Satisfaction of Daratumumab Use in the Treatment of First-line Daratumumab, Lenalidomide, Dexamethasone (DRd) Multiple Myeloma Patients as Per Routine Clinical Practice in Germany Depending on Application Route (sc or iv)Status: Active (not recruiting), Estimated PCD: 2024-09-30